| Date Initiated by Firm | June 25, 2025 |
| Date Posted | April 03, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1772-2026 |
| Recall Event ID |
98553 |
| Product Classification |
Panels, test, susceptibility, antimicrobial - Product Code LTT
|
| Product | MicroScan Neg MIC 3J REF C54814 |
| Code Information |
Catalog Number: C54814
UDI code: N/A
Lot Number: 2025-08-23 |
| FEI Number |
2919016
|
Recalling Firm/ Manufacturer |
Beckman Coulter, Inc. 2040 Enterprise Blvd West Sacramento CA 95691-3427
|
| For Additional Information Contact | Kurtis Montegna 530-990-3496 |
Manufacturer Reason for Recall | Due to a manufacturing issue - missing a drug in well 4/4 but contain double the amount of antibiotics |
FDA Determined Cause 2 | Process control |
| Action | On 07/15/2024, firm sent via mail/email an "URGENT MEDICAL DEVICE RECALL" Letter to customer inform them that customers have reported multiple patient samples with skipped wells for Ceftolozane/Tazobactam (C/T) when tested with MicroScan Neg MIC 3J Lot 2025-08-23. The C/T 2/4 dilution well exhibited no growth while growth was observed in the C/T 4/4 well.
Customers are instructed to:
"Discontinue use of this lot and discard per your laboratory guidelines.
"Consider reviewing the C/T antimicrobial susceptibility test results from this lot if Enterobacterales reported as resistant and P. aeruginosa reported as intermediate or if an increasing trend in resistance has been observed for C/T in your laboratory.
"The laboratory should retain the inventory of other MicroScan Neg MIC 3J lots as they are not impacted by this issue.
any questions regarding this notice, please contact us:
"From our website: http://www.beckmancoulter.com
"By phone: please contact: Customer call center TEL :0120-566-730 |
| Quantity in Commerce | 688 boxes (20 panels per box) |
| Distribution | International distribution in the country of Japan. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|